 | • レポートコード：QYR2104Z5265 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、シェーグレン症候群治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（一次、二次）、用途別市場規模（臨床、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・シェーグレン症候群治療薬の市場動向 ・企業の競争状況、市場シェア ・シェーグレン症候群治療薬の種類別市場規模（一次、二次） ・シェーグレン症候群治療薬の用途別市場規模（臨床、病院） ・シェーグレン症候群治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・シェーグレン症候群治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・シェーグレン症候群治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・シェーグレン症候群治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・シェーグレン症候群治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Biogen、Bristol-Myers Squibb、F. Hoffmann-La Roche、Novartis、Kissei Pharmaceutical、Aldeyra Therapeutics、GlaxoSmithKline、Biogen） ・結論 |
Sjogren’s syndrome is an inflammatory disorder characterized by lymphocytic infiltrates in exocrine organs, primarily in lacrimal and salivary glands, resulting in classic sicca symptoms of dry mouth (xerostomia) and dry eyes (xerophthalmia).
The disorder segmented into primary and secondary. The disorder that occurs in the absence of other autoimmune disease, such as lupus, rheumatoid arthritis, or scleroderma is known as primary Sjogren’s syndrome. The one that occurs due to presence of other autoimmune diseases is known as secondary Sjogren’s syndrome.
Market Analysis and Insights: Global Sjogren’s Syndrome Therapeutics Market
The global Sjogren’s Syndrome Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sjogren’s Syndrome Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sjogren’s Syndrome Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sjogren’s Syndrome Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sjogren’s Syndrome Therapeutics market.
Global Sjogren’s Syndrome Therapeutics Scope and Market Size
Sjogren’s Syndrome Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sjogren’s Syndrome Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Primary
Secondary
Segment by Application
Clinical
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Biogen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Novartis
Kissei Pharmaceutical
Aldeyra Therapeutics
GlaxoSmithKline
Biogen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sjogren’s Syndrome Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Primary
1.2.3 Secondary
1.3 Market by Application
1.3.1 Global Sjogren’s Syndrome Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sjogren’s Syndrome Therapeutics Market Perspective (2016-2027)
2.2 Sjogren’s Syndrome Therapeutics Growth Trends by Regions
2.2.1 Sjogren’s Syndrome Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sjogren’s Syndrome Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Sjogren’s Syndrome Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Sjogren’s Syndrome Therapeutics Industry Dynamic
2.3.1 Sjogren’s Syndrome Therapeutics Market Trends
2.3.2 Sjogren’s Syndrome Therapeutics Market Drivers
2.3.3 Sjogren’s Syndrome Therapeutics Market Challenges
2.3.4 Sjogren’s Syndrome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sjogren’s Syndrome Therapeutics Players by Revenue
3.1.1 Global Top Sjogren’s Syndrome Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Sjogren’s Syndrome Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Sjogren’s Syndrome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sjogren’s Syndrome Therapeutics Revenue
3.4 Global Sjogren’s Syndrome Therapeutics Market Concentration Ratio
3.4.1 Global Sjogren’s Syndrome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sjogren’s Syndrome Therapeutics Revenue in 2020
3.5 Sjogren’s Syndrome Therapeutics Key Players Head office and Area Served
3.6 Key Players Sjogren’s Syndrome Therapeutics Product Solution and Service
3.7 Date of Enter into Sjogren’s Syndrome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sjogren’s Syndrome Therapeutics Breakdown Data by Type
4.1 Global Sjogren’s Syndrome Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Sjogren’s Syndrome Therapeutics Forecasted Market Size by Type (2022-2027)
5 Sjogren’s Syndrome Therapeutics Breakdown Data by Application
5.1 Global Sjogren’s Syndrome Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Sjogren’s Syndrome Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sjogren’s Syndrome Therapeutics Market Size (2016-2027)
6.2 North America Sjogren’s Syndrome Therapeutics Market Size by Type
6.2.1 North America Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Sjogren’s Syndrome Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2027)
6.3 North America Sjogren’s Syndrome Therapeutics Market Size by Application
6.3.1 North America Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Sjogren’s Syndrome Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2027)
6.4 North America Sjogren’s Syndrome Therapeutics Market Size by Country
6.4.1 North America Sjogren’s Syndrome Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Sjogren’s Syndrome Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Sjogren’s Syndrome Therapeutics Market Size (2016-2027)
7.2 Europe Sjogren’s Syndrome Therapeutics Market Size by Type
7.2.1 Europe Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Sjogren’s Syndrome Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2027)
7.3 Europe Sjogren’s Syndrome Therapeutics Market Size by Application
7.3.1 Europe Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Sjogren’s Syndrome Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2027)
7.4 Europe Sjogren’s Syndrome Therapeutics Market Size by Country
7.4.1 Europe Sjogren’s Syndrome Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Sjogren’s Syndrome Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Type
8.2.1 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Application
8.3.1 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Region
8.4.1 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sjogren’s Syndrome Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sjogren’s Syndrome Therapeutics Market Size (2016-2027)
9.2 Latin America Sjogren’s Syndrome Therapeutics Market Size by Type
9.2.1 Latin America Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Sjogren’s Syndrome Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Sjogren’s Syndrome Therapeutics Market Size by Application
9.3.1 Latin America Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Sjogren’s Syndrome Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Sjogren’s Syndrome Therapeutics Market Size by Country
9.4.1 Latin America Sjogren’s Syndrome Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Sjogren’s Syndrome Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Type
10.2.1 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Application
10.3.1 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Country
10.4.1 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sjogren’s Syndrome Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Sjogren’s Syndrome Therapeutics Introduction
11.1.4 Allergan Revenue in Sjogren’s Syndrome Therapeutics Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Sjogren’s Syndrome Therapeutics Introduction
11.2.4 Biogen Revenue in Sjogren’s Syndrome Therapeutics Business (2016-2021)
11.2.5 Biogen Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Sjogren’s Syndrome Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Sjogren’s Syndrome Therapeutics Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Sjogren’s Syndrome Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Sjogren’s Syndrome Therapeutics Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Sjogren’s Syndrome Therapeutics Introduction
11.5.4 Novartis Revenue in Sjogren’s Syndrome Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Kissei Pharmaceutical
11.6.1 Kissei Pharmaceutical Company Details
11.6.2 Kissei Pharmaceutical Business Overview
11.6.3 Kissei Pharmaceutical Sjogren’s Syndrome Therapeutics Introduction
11.6.4 Kissei Pharmaceutical Revenue in Sjogren’s Syndrome Therapeutics Business (2016-2021)
11.6.5 Kissei Pharmaceutical Recent Development
11.7 Aldeyra Therapeutics
11.7.1 Aldeyra Therapeutics Company Details
11.7.2 Aldeyra Therapeutics Business Overview
11.7.3 Aldeyra Therapeutics Sjogren’s Syndrome Therapeutics Introduction
11.7.4 Aldeyra Therapeutics Revenue in Sjogren’s Syndrome Therapeutics Business (2016-2021)
11.7.5 Aldeyra Therapeutics Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Sjogren’s Syndrome Therapeutics Introduction
11.8.4 GlaxoSmithKline Revenue in Sjogren’s Syndrome Therapeutics Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Sjogren’s Syndrome Therapeutics Introduction
11.9.4 Biogen Revenue in Sjogren’s Syndrome Therapeutics Business (2016-2021)
11.9.5 Biogen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sjogren's Syndrome Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Primary
Table 3. Key Players of Secondary
Table 4. Global Sjogren's Syndrome Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Sjogren's Syndrome Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sjogren's Syndrome Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Sjogren's Syndrome Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Sjogren's Syndrome Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Sjogren's Syndrome Therapeutics Market Share by Regions (2022-2027)
Table 10. Sjogren's Syndrome Therapeutics Market Trends
Table 11. Sjogren's Syndrome Therapeutics Market Drivers
Table 12. Sjogren's Syndrome Therapeutics Market Challenges
Table 13. Sjogren's Syndrome Therapeutics Market Restraints
Table 14. Global Sjogren's Syndrome Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Sjogren's Syndrome Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Sjogren's Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sjogren's Syndrome Therapeutics as of 2020)
Table 17. Ranking of Global Top Sjogren's Syndrome Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Sjogren's Syndrome Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sjogren's Syndrome Therapeutics Product Solution and Service
Table 21. Date of Enter into Sjogren's Syndrome Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sjogren's Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Sjogren's Syndrome Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Sjogren's Syndrome Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Sjogren's Syndrome Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Sjogren's Syndrome Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Sjogren's Syndrome Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Sjogren's Syndrome Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Sjogren's Syndrome Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Sjogren's Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Sjogren's Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Sjogren's Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Sjogren's Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Sjogren's Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Sjogren's Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Sjogren's Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Sjogren's Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Sjogren's Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Sjogren's Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Sjogren's Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Sjogren's Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Sjogren's Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Sjogren's Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Sjogren's Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Sjogren's Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sjogren's Syndrome Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Sjogren's Syndrome Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Sjogren's Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Sjogren's Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Sjogren's Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Sjogren's Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Sjogren's Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Sjogren's Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Sjogren's Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Sjogren's Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Sjogren's Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Sjogren's Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sjogren's Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Sjogren's Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Allergan Company Details
Table 62. Allergan Business Overview
Table 63. Allergan Sjogren's Syndrome Therapeutics Product
Table 64. Allergan Revenue in Sjogren's Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Allergan Recent Development
Table 66. Biogen Company Details
Table 67. Biogen Business Overview
Table 68. Biogen Sjogren's Syndrome Therapeutics Product
Table 69. Biogen Revenue in Sjogren's Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Biogen Recent Development
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Sjogren's Syndrome Therapeutics Product
Table 74. Bristol-Myers Squibb Revenue in Sjogren's Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. F. Hoffmann-La Roche Company Details
Table 77. F. Hoffmann-La Roche Business Overview
Table 78. F. Hoffmann-La Roche Sjogren's Syndrome Therapeutics Product
Table 79. F. Hoffmann-La Roche Revenue in Sjogren's Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 80. F. Hoffmann-La Roche Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Sjogren's Syndrome Therapeutics Product
Table 84. Novartis Revenue in Sjogren's Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Kissei Pharmaceutical Company Details
Table 87. Kissei Pharmaceutical Business Overview
Table 88. Kissei Pharmaceutical Sjogren's Syndrome Therapeutics Product
Table 89. Kissei Pharmaceutical Revenue in Sjogren's Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Kissei Pharmaceutical Recent Development
Table 91. Aldeyra Therapeutics Company Details
Table 92. Aldeyra Therapeutics Business Overview
Table 93. Aldeyra Therapeutics Sjogren's Syndrome Therapeutics Product
Table 94. Aldeyra Therapeutics Revenue in Sjogren's Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Aldeyra Therapeutics Recent Development
Table 96. GlaxoSmithKline Company Details
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Revenue in Sjogren's Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 99. GlaxoSmithKline Recent Development
Table 100. Biogen Company Details
Table 101. Biogen Business Overview
Table 102. Biogen Sjogren's Syndrome Therapeutics Product
Table 103. Biogen Revenue in Sjogren's Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Biogen Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sjogren's Syndrome Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Primary Features
Figure 3. Secondary Features
Figure 4. Global Sjogren's Syndrome Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Clinical Case Studies
Figure 6. Hospital Case Studies
Figure 7. Sjogren's Syndrome Therapeutics Report Years Considered
Figure 8. Global Sjogren's Syndrome Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Sjogren's Syndrome Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Sjogren's Syndrome Therapeutics Market Share by Regions: 2020 VS 2027
Figure 11. Global Sjogren's Syndrome Therapeutics Market Share by Regions (2022-2027)
Figure 12. Global Sjogren's Syndrome Therapeutics Market Share by Players in 2020
Figure 13. Global Top Sjogren's Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sjogren's Syndrome Therapeutics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Sjogren's Syndrome Therapeutics Revenue in 2020
Figure 15. Global Sjogren's Syndrome Therapeutics Revenue Market Share by Type (2016-2021)
Figure 16. Global Sjogren's Syndrome Therapeutics Revenue Market Share by Type (2022-2027)
Figure 17. North America Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Sjogren's Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 19. North America Sjogren's Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 20. North America Sjogren's Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 21. United States Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Sjogren's Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 25. Europe Sjogren's Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 26. Europe Sjogren's Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 27. Germany Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Sjogren's Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Sjogren's Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Sjogren's Syndrome Therapeutics Market Share by Region (2016-2027)
Figure 37. China Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Sjogren's Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 45. Latin America Sjogren's Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 46. Latin America Sjogren's Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 47. Mexico Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Sjogren's Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Sjogren's Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Sjogren's Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 53. Turkey Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Sjogren's Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Allergan Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2016-2021)
Figure 57. Biogen Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2016-2021)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2016-2021)
Figure 61. Kissei Pharmaceutical Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2016-2021)
Figure 62. Aldeyra Therapeutics Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2016-2021)
Figure 64. Biogen Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の骨髄異形成症候群（MDS）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Myelodysplastic Syndrome (MDS) Therapeutics Market The global Myelodysplastic Syndrome (MDS) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in …- 世界の重症急性呼吸器症候群（SARS）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market The global Severe Acute Respiratory Syndrome (SARS) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-s…
- 世界のレット症候群治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Rett Syndrome Therapeutics Market The global Rett Syndrome Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Dravet Syndrome Thereapeutics Market The global Dravet Syndrome Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Dravet Syndrome Thereapeutics Market The global Dravet Syndrome Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…